Magnosco GmbH

Magnosco GmbH, founded in 2014, is a MedTec Company based in the technology park Berlin-Adlershof. We offer a non-invasive method supporting (early) detection of malignant melanoma based on laser technology. CEO Inga Bergen and COO Thomas Diepold lead the team of scientist and technical experts. Magnosco cooperates with Charite Berlin, University Hospital of Tubingen and the University Hospital of Heidelberg, hospital operator Vivantes and LTB Lasertechnik Berlin regarding the development and certification as a medical device. More and more people know that if skin lesions are changing a doctors expertise is very important to detect skin cancer early on. Especially...

Dermatofluoroscopy,early cancer detection,malignant melanoma,skin cancer,skin detection,laser spectroscopy,future medicine,dermatology,optics,artificial intelligence,and big data

Magnosco gmbh operates in the Medical device industry.

Magnosco gmbh's revenue is 11m - 100m

Magnosco gmbh has 11 - 50 employees.